Application 060613

Type
NDA
Sponsor
CASPER PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CASPORYN HCHYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATESUSPENSION/DROPS;OTIC1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
64980-448Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin B sulfates and hydrocortisone oticRising Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
64980-448Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin B sulfates and hydrocortisone oticRising Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
64980-448Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin B sulfates and hydrocortisone oticRising Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
68788-7787Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin B sulfates and hydrocortisone oticPreferred Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
68788-7787Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin B sulfates and hydrocortisone oticPreferred Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
68788-7787Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspensionneomycin and polymyxin B sulfates and hydrocortisone oticPreferred Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
70199-011CASPORYN HCneomycin and polymyxin B sulfates and hydrocortisone oticCasper Pharma LLCNDACurrent
70199-011CASPORYN HCneomycin and polymyxin B sulfates and hydrocortisone oticCasper Pharma LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79693SUPPL 2024-09-23
79661SUPPL 2024-09-23
50819SUPPL2017-12-21